Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.40

EBS FY 2006 Earnings — Emergent BioSolutions Inc. Revenue & Financial Results | Market Cap Arena

EBSEmergent BioSolutions Inc.

$427M

FY 2006 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$153M

Gross Profit

$129M84.2% margin

Operating Income

$38M24.9% margin

Net Income

$23M14.9% margin

EPS (Diluted)

$0.93

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$45M

Stock-Based Comp.

$723,000

Balance Sheet

Total Assets

$238M

Total Liabilities

$100M

Stockholders' Equity

$138M

Cash & Equivalents

$76M

← FY 2007 All Quarters